BDR unsponsored
D2NL34 — DENALI THERAPEUTICS INC
Unsponsored: a depositary bank issues it on its own; the foreign company does not file anything with the CVM.
1m +38.6% · 12m +61.5% · YTD +25.6% · 52-week R$ 13.75–27.42
last 60 sessions it traded
with distributionsprice change plus distributions reinvested on the ex-date
Price
Closing price as traded on B3, in reais, not adjusted.
Return by window
| 1 month | 3 months | 1 year | 2 years | 5 years | 10 years | |
|---|---|---|---|---|---|---|
| With distributions | +38.6% | +26.8% | +61.5% | +33.8% | — | — |
| Price only | +38.6% | +26.8% | +61.5% | +33.8% | — | — |
| Real (net of IPCA) | — | — | — | — | — | — |
In reais: the BDR return already includes the exchange rate move, because the price is in reais.
Distributions
B3 lists no distribution for this BDR.
Take this into your code
GET /bdrs/D2NL34 with Accept: application/json and the X-API-Key header (AAPL34 answers without a key). Daily series at GET /bdrs/D2NL34/precos. Free key, no card.Coverage: 71 sessions, 2024-02-20 → 2026-07-13 · sources: B3 (COTAHIST, BDR list and company supplement) · Descriptive, not a recommendation.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-12 23:04 UTC. If this does not match /saude, you are reading a cached copy.